Patent directory · USPTO A61K / A61P
Patents matching “ERNA”
213 pharma patents match "ERNA" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 213 pharmaceutical patents matching "ERNA" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11478428
Combinations of beta-lactam compounds and probenecid and uses thereof
granted -
AU 2021230529
Use of compounds in the treatment of fungal infections
granted -
US 11447563
Tumor selective macropinocytosis-dependent rapidly internalizing antibodies
granted -
US 11446253
Ionic liquids for internal delivery
granted -
US 11446357
Method for treating disease using FOXP3+CD4+ T cells
granted -
US 11420945
Solid state forms of Pemafibrate
granted -
US 11407820
Modulating the alternative complement pathway
granted -
US 11306104
Solid state forms of Relugolix
granted -
US 11278493
Ophthalmic formulations providing durable ocular lubrication
granted -
US 11253445
Oxidative hair color remover in tablet or pellet form
granted -
US 11220488
Crystalline polymorph of Ponesimod
granted -
US 11208458
Compositions and methods for internalizing enzymes
granted -
US 11208493
Internalizing human monoclonal antibodies targeting prostate and other cancer cells
granted -
US 11186626
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
granted -
US 11161828
Class of bisquaternary ammonium compound as well as the preparative method and the use thereof
granted -
US 11124835
Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers
granted -
US 11078485
Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
granted -
US 11053261
Solid state forms of ixazomib citrate
granted -
US 11033631
Methods of treating CYP2D6 alternative metabolizers
granted -
US 11028160
Treating refractory migraine
granted -
US 11028161
Treating refractory migraine
granted -
US 11008564
Processing engineered FMDV P1 polypeptide using an alternative TEV protease
granted -
AU 2019328599
Compounds and methods for treating fungal infections
granted -
US 10981896
Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase
granted